Home Diplomacy US donates new HIV prevention drug to Mozambique
DiplomacyHealth

US donates new HIV prevention drug to Mozambique

Share
Share

Maputo – The United States has pledged to donate Lenacapavir, an FDA-approved injectable drug given twice a year for HIV prevention, to Mozambique as part of a pioneering global programme.

Abigail L. Dressel, Business Manager at the U.S. Embassy in Mozambique, announced the donation during a meeting with Health Minister Ussene Isse. Mozambique is one of ten countries worldwide selected for the initiative under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).

Clinical trials by Gilead showed that over 99% of participants remained HIV negative, demonstrating the potential of Lenacapavir to transform HIV prevention. The donation forms part of ongoing efforts by the United States to support life-saving health programmes and strengthen Mozambique’s public health system.

Share
Written by
Adekunle Owolabi

Adekunle Owolabi is a journalist, political analyst, and digital strategist with experience across Africa and the Middle East. He focuses on international diplomacy, promotes digital inclusion, and advocates for a borderless Africa.

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Nigeria and Mozambique sign diplomatic cooperation deal

Abuja, Nigeria: Nigeria and Mozambique have agreed to strengthen diplomatic cooperation through...

Russia, China and US adopt joint peace declaration

Shenzhen, China: Russian President Vladimir Putin, Chinese President Xi Jinping and US...

Kushner says Russia open to NATO-style guarantees for Ukraine

Berlin, Germany: US President Donald Trump’s special envoy Jared Kushner has said...

Tripartite trade regime targets small-scale traders

BUSIA, Kenya – Regional trade officials, border agencies and representatives of traders'...